New Therapies Targeting apoB Metabolism for High-Risk Patients with Inherited Dyslipidaemias: What Can the Clinician Expect?

Author: Sahebkar Amirhossein   Watts Gerald  

Publisher: Springer Publishing Company

ISSN: 0920-3206

Source: Cardiovascular Drugs and Therapy, Vol.27, Iss.6, 2013-12, pp. : 559-567

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract